Evidence map›Paper›PMID 30209945›Full record

ArticleJournal of proteome research2018

Label-Free Proteomic Approach to Characterize Protease-Dependent and -Independent Effects of sarA Inactivation on the Staphylococcus aureus Exoproteome.

Stephanie D Byrum, Allister J Loughran, Karen E Beenken, Lisa M Orr, Aaron J Storey, Samuel G Mackintosh, Ricky D Edmondson, Alan J Tackett, Mark S Smeltzer

Open access · greenAbstract read
In one paragraph

Article in Journal of proteome research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. The secreted proteasesVirulence · 2025
    Article
  3. Microorganisms · 2025
    Review
  4. The ability ofInfection and immunity · 2025
    Article
  5. Microorganisms · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. The major role ofVirulence · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Impacts ofInfection and immunity · 2020
    Article
  17. Article
  18. Article
  19. Enhancement of Cellulase Production inFrontiers in microbiology · 2019
    Article
  20. Assessing the Contribution of an HtrA Family Serine Protease DuringFrontiers in cellular and infection microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Stephanie D ByrumDepartment of Biochemistry and Molecular Biology , University of Arkansas for Medical Sciences , 4301 West Markham Street , Little Rock , Arkansas 72205 , United States.
Allister J LoughranDepartment of Microbiology and Immunology , University of Arkansas for Medical Sciences , 4301 West Markham Street , Little Rock , Arkansas 72205 , United States.
Karen E BeenkenDepartment of Microbiology and Immunology , University of Arkansas for Medical Sciences , 4301 West Markham Street , Little Rock , Arkansas 72205 , United States.
Lisa M OrrDepartment of Biochemistry and Molecular Biology , University of Arkansas for Medical Sciences , 4301 West Markham Street , Little Rock , Arkansas 72205 , United States.
Aaron J StoreyDepartment of Biochemistry and Molecular Biology , University of Arkansas for Medical Sciences , 4301 West Markham Street , Little Rock , Arkansas 72205 , United States.
Samuel G MackintoshDepartment of Biochemistry and Molecular Biology , University of Arkansas for Medical Sciences , 4301 West Markham Street , Little Rock , Arkansas 72205 , United States.
Ricky D EdmondsonDepartment of Biochemistry and Molecular Biology , University of Arkansas for Medical Sciences , 4301 West Markham Street , Little Rock , Arkansas 72205 , United States.
Alan J TackettDepartment of Biochemistry and Molecular Biology , University of Arkansas for Medical Sciences , 4301 West Markham Street , Little Rock , Arkansas 72205 , United States.ORCID 0000-0002-3672-4460
Mark S SmeltzerDepartment of Microbiology and Immunology , University of Arkansas for Medical Sciences , 4301 West Markham Street , Little Rock , Arkansas 72205 , United States.ORCID 0000-0002-0878-0692
University of Arkansas for Medical Sciences · USArkansas Children's Hospital · US

Funding

Understanding Hesitant AdoptersP20GM103429 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Lawrence E Cornett, JERRY WARE · 2012 to 2026
$60.9M
Translational Regulation in Normal Erythropoiesis and Diamond Blackfan AnemiaP20GM121293 · NIGMS · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI Samrat Roy Choudhury · 2017 to 2026
$27.6M
Study of the Cell-specific Inflammasome Responses During Defense Against Gram-negative BacteriaP20GM103625 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI SMELTZER, MARK S · 2012 to 2021
$21.5M
Arkansas Center for Clinical and Translational ResearchUL1TR000039 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI BECK, CORNELIA MARIE, JAMES, LAURA P · 2012 to 2014
$10.0M
Pilot Grant ProgramP30GM145393 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Jason S Stumhofer · 2022 to 2026
$7.6M
Impact of Staphylococcus aureus in osteomyelitis and bone physiologyR01AI119380 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI BEENKEN, KAREN E., SMELTZER, MARK S · 2015 to 2025
$4.1M
Orbitrap Fusion Tribrid Mass SpectrometerS10OD018445 · OD · UNIV OF ARKANSAS FOR MED SCIS · PI MACKINTOSH, SAMUEL G. · 2015 to 2015
$856k
Technology for Identification of Epiproteomes in Tissue SamplesR21DA041822 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI TACKETT, ALAN · 2016 to 2017
$373k
NCATS NIH HHS UL1 TR000039NIAID NIH HHS R01 AI119380NIDA NIH HHS R21 DA041822NIGMS NIH HHS P20 GM103429NIGMS NIH HHS P20 GM103625NIGMS NIH HHS P20 GM121293NIGMS NIH HHS P30 GM145393NIH HHS S10 OD018445
6 · The paper itself

Abstract

The staphylococcal accessory regulator A ( sarA) impacts the extracellular accumulation of Staphylococcus aureus virulence factors at the level of intracellular production and extracellular protease-mediated degradation. We previously used a proteomics approach that measures protein abundance of all proteoforms to demonstrate that mutation of sarA results in increased levels of extracellular proteases and assesses the impact of this on the accumulation of S. aureus exoproteins. Our previous approach was limited as it did not take into account that large, stable proteolytic products from a given protein could result in false negatives when quantified by total proteoforms. Here, our goal was to use an expanded proteomics approach utilizing a dual quantitative method for measuring abundance at both the total proteoform and full-length exoprotein levels to alleviate these false negatives and thereby provide for characterization of protease-dependent and -independent effects of sarA mutation on the S. aureus exoproteome. Proteins present in conditioned medium from overnight, stationary phase cultures of the USA300 strain LAC, an isogenic sarA mutant, and a sarA mutant unable to produce any of the known extracellular proteases ( sarA/protease) were resolved using one-dimensional gel electrophoresis. Quantitative proteomic comparisons of sarA versus sarA/protease mutants identified proteins that were cleaved in a protease-dependent manner owing to mutation of sarA, and comparisons of sarA/protease mutant versus the LAC parent strain identified proteins in which abundance was altered in a sarA mutant in a protease-independent manner. Furthermore, the proteins uniquely identified by the full-length data analysis approach eliminated false negatives observed in the total proteoform analysis. This expanded approach provided for a more comprehensive analysis of the impact of mutating sarA on the S. aureus exoproteome.

Indexed as

Bacterial ProteinsBiofilmsGene Expression Regulation, BacterialMethicillin-Resistant Staphylococcus aureusMutationPeptide HydrolasesProteomeProteomicsStaphylococcus aureusTandem Mass SpectrometryVirulenceBacterial ProteinsPeptide HydrolasesProteomeSarA protein, Staphylococcus aureusmass spectrometryproteaseproteolysisproteomicssarAStaphylococcus aureus

Identifiers

PMID30209945
PMCPMC6209314
OpenAlexW2892041266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.